Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Ocular Surface Disease > Study examines impact of cataract surgery on dry eye outcomes
  • Ocular Surface Disease

Study examines impact of cataract surgery on dry eye outcomes

Kelsey Moroz

Dry eye symptoms are a common complication after cataract surgery and may persist for up to 3 months postoperatively, according to a study that highlights the importance of monitoring and managing dry eye to optimize visual outcomes, patient satisfaction, and quality of life.

A recent systematic review analyzed data from 20 studies involving 1,694 eyes to assess the effect of cataract surgery on dry eye outcomes. Researchers evaluated changes in dry eye indicators such as Ocular Surface Disease Index (OSDI), tear break-up time (TBUT), Schirmer’s I test (ST1), and corneal fluorescein staining (CFS) over short-term (within 1 week) and medium-term (up to 3 months) postoperative periods.

There was a reduction in TBUT during both timeframes, suggesting a decline in tear film stability. Other measures, including ST1 and CFS, often showed deterioration at medium-term follow-up, though evidence regarding OSDI was inconsistent. The variability in study methodologies and follow-up durations limited the ability to track the peak and duration of dry eye symptoms.

Overall, the review highlights that dry eye symptoms may persist for up to 3 months after cataract surgery. Further research is needed to determine whether these outcomes resolve over a longer term.

Reference
Ta H, McCann P, Xiao M, et al. Dry eye post-cataract surgery: a systematic review and meta-analysis. BMC Ophthalmol. 2025;25(1):18. doi: 10.1186/s12886-024-03841-8. PMID: 39806338.

Share

Related Content

  • Dry Eye

Preservative-free lubricants linked to improved dry eye symptoms in real-world study

  • Ocular Surface Disease

Scleral lenses improve vision and symptoms across ocular surface diseases

  • Dry Eye

Spotlight on LACRIFILL®

  • Conference Roundup

CAM360 with a collagen shield provides rapid epithelial healing with better tolerability and safety than when used with bandage contact lenses

  • Conference Roundup

If your patient has recurrent chalazia, consider co-occurring Demodex blepharitis

  • Conference Roundup

Ocular staining and dry mouth may help identify Sjögren’s-related dry eye

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon